Yuen E C, Mobley W C
Department of Neurology, University of California, San Francisco, USA.
Mol Med Today. 1995 Sep;1(6):278-86. doi: 10.1016/s1357-4310(95)91189-8.
Research in the past few years has produced exciting progress in our understanding of neurotrophic factors. Robust effects of neurotrophic factors on neuronal survival and differentiation in animal studies have encouraged initiation of clinical trials for diseases of the human nervous system. In this article, the data for the actions of neurotrophic factors and the rationale for their use in clinical trials are reviewed. Recent data demonstrating efficacy of insulin-like growth factor 1 in amyotrophic lateral sclerosis suggest that neurotrophic factors can be used to treat neurological disease.
在过去几年的研究中,我们对神经营养因子的理解取得了令人振奋的进展。神经营养因子在动物研究中对神经元存活和分化具有显著作用,这促使人们启动了针对人类神经系统疾病的临床试验。在本文中,我们将综述神经营养因子作用的数据及其在临床试验中应用的理论依据。最近有数据表明胰岛素样生长因子1对肌萎缩侧索硬化症有效,这表明神经营养因子可用于治疗神经疾病。